Anne Phillips Net Worth

Anne Phillips biography

Dr. Anne M. Phillips M.D. serves as Independent Director of the Company. Dr. Phillips currently holds the position of Senior Vice President, Clinical Development, Medical and Regulatory Affairs at Novo Nordisk, Inc., a pharmaceutical company, where she has served since 2011. Prior to Novo Nordisk, Dr. Phillips served in various roles of increasing responsibility from 1998 to 2010 at GlaxoSmithKline plc, a global healthcare company. Dr. Phillips also served as the Head of the Infectious Diseases Program and Deputy Physician-in-Chief at Wellesley Central Hospital/St. Michael's Hospital in Toronto, Canada. She has been a member of the Board of Directors of Trevena, Inc., a public biopharmaceutical company, since December 2014, where she is also a member on the Nominating and Corporate Governance Committee and Compensation Committee. Dr. Phillips is a Fellow of The Royal College of Physicians and Surgeons of Canada, earned an M.D. from the University of Toronto and received a BSc from the University of Western Ontario. The Board believes that Dr. Phillips' broad-based expertise in the pharmaceutical industry leading clinical research and development, medical, and regulatory functions, as well as her medical training, allows her to make valuable contributions to the medical and scientific understanding of the Board, which is particularly important given our expansive development pipeline, including our AMAG-423 and ciraparantag products.

What is the salary of Anne Phillips?

As the Independent Director of AMAG Pharmaceuticals, the total compensation of Anne Phillips at AMAG Pharmaceuticals is $261,829. There are 4 executives at AMAG Pharmaceuticals getting paid more, with Joseph Vittiglio having the highest compensation of $1,411,860.

How old is Anne Phillips?

Anne Phillips is 66, he's been the Independent Director of AMAG Pharmaceuticals since 2019. There are 3 older and 9 younger executives at AMAG Pharmaceuticals. The oldest executive at AMAG Pharmaceuticals, Inc. is Davey Scoon, 73, who is the Independent Director.

What's Anne Phillips's mailing address?

Anne's mailing address filed with the SEC is C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, SUITE 310, HIGH POINT, NC, 27265.

Insiders trading at AMAG Pharmaceuticals

Over the last 18 years, insiders at AMAG Pharmaceuticals have traded over $162,079,471 worth of AMAG Pharmaceuticals stock and bought 3,622,220 units worth $65,172,892 . The most active insiders traders include Capital, Llc Armistice Capi..., Capital Partners Gp, L.L.C.... és Capital Management Lp Camber. On average, AMAG Pharmaceuticals executives and independent directors trade stock every 42 days with the average trade being worth of $2,148,850. The most recent stock trade was executed by Capital Management Lp Camber on 1 October 2020, trading 4,390,000 units of AMAG stock currently worth $59,572,300.

What does AMAG Pharmaceuticals do?

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.

AMAG Pharmaceuticals executives and stock owners

AMAG Pharmaceuticals executives and other stock owners filed with the SEC include:

• Joseph Vittiglio,
  Executive Vice President, General Counsel, Corporate Secretary, Chief Business Officer
• Anthony Casciano,
  Chief Operating Officer, Executive Vice President and Chief Commercial Officer
• Gino Santini,
  Independent Chairman of the Board
• Kathrine O'Brien,
  Independent Director
• Anne Phillips,
  Independent Director
• Davey Scoon,
  Independent Director
• John Fallon,
  Independent Director
• James Sulat,
  Independent Director
• David Johnson,
  Independent Director
• Paul Fonteyne,
  Independent Director
• Linda Lennox,
  Vice President - Investor Relations and Corporate Communications
• Nancy Griffith,
  Vice President - Scientific Communications And Medical Operations
• Kelly Schick,
  Chief Human Resource Officer, Senior Vice President
• Brian Piekos,
  Chief Financial Officer
• Scott Myers,
  President, Chief Executive Officer, Director
• Barbara Deptula,
  Director
• Brian P Kelley,
  Director
• Lesley Russell,
  Director
• Robert J Perez,
  Director
• Edward H Myles,
  COO & CFO
• William K Heiden,
  President & CEO
• Nicholas Grund,
  Chief Commercial Officer
• Elizabeth Scott Bolgiano,
  Chief Human Resources Officer
• Partners Lp Caligan,
  10% owner
• Julie Krop,
  Chief Medical Officer
• James Alan Butcher,
  EVP, Chief Business Officer
• Capital Management Lp Camber,
  
• Capital, Llc Armistice Capi...,
  
• Kenneth H Wilson,
  SVP, Sales and Marketing
• Geoffrey Crouse,
  EVP
• Edward P. Jordan,
  SVP, Sales and Marketing
• Scott B Townsend,
  SVP, General Counsel
• Capital Partners Gp, L.L.C....,
  
• Steven Caffe,
  SVP, Ch. Dev. and Reg. Officer
• Ron Zwanziger,
  Director
• Michael Narachi,
  Director
• Sheldon L Bloch,
  Director
• Christopher G White,
  Chief Business Officer and SVP
• Jerome M Lewis,
  VP of Scientific Operations
• David Arkowitz,
  CFO & Chief Business Officer
• Jerome Goldstein,
  CEO and Treasurer
• Ricardo Zayas,
  Sr. Vice President, Operations
• Mark B Skaletsky,
  Director
• Silva Rajiv De,
  Director
• Gary J Zieziula,
  EVP, Chief Commercial Officer
• Michael D Loberg,
  Director
• Frank E Thomas,
  President & COO
• Michael N Avallone,
  VP-Finance and CFO
• Scott A Holmes,
  Chief Accounting Officer
• Joseph Vincent Bonventre,
  Director
• Brian Jg Pereira,
  President and CEO
• Greg Madison,
  EVP, Chief Commercial Officer
• Theodore I Steinman,
  Director
• Edward B Roberts,
  Director
• Timothy G Healey,
  SVP-Commercial Operations
• Lee F Md Ph D Allen,
  CMO & SVP Clinical Dev.
• Joseph L Farmer,
  Gen Counsel & VP Legal Affairs
• Louis Md Brenner,
  Senior Vice President